These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 33207783)
21. Aromatase in the context of breast and endometrial cancer. A review. Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363 [TBL] [Abstract][Full Text] [Related]
22. Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells. Amaral C; Varela CL; Maurício J; Sobral AF; Costa SC; Roleira FMF; Tavares-da-Silva EJ; Correia-da-Silva G; Teixeira N J Steroid Biochem Mol Biol; 2017 Jul; 171():218-228. PubMed ID: 28396197 [TBL] [Abstract][Full Text] [Related]
23. Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer. Yadav MR; Barmade MA; Tamboli RS; Murumkar PR Eur J Med Chem; 2015 Nov; 105():1-38. PubMed ID: 26469743 [TBL] [Abstract][Full Text] [Related]
24. From nonsteroidal aromatase inhibitors to multifunctional drug candidates: classic and innovative strategies for the treatment of breast cancer. Gobbi S; Cavalli A; Bisi A; Recanatini M Curr Top Med Chem; 2008; 8(10):869-87. PubMed ID: 18673172 [TBL] [Abstract][Full Text] [Related]
25. A review on diverse heterocyclic compounds as the privileged scaffolds in non-steroidal aromatase inhibitors. Rani S; Raheja K; Luxami V; Paul K Bioorg Chem; 2021 Aug; 113():105017. PubMed ID: 34091288 [TBL] [